BCKDK Antikörper (N-Term)
Kurzübersicht für BCKDK Antikörper (N-Term) (ABIN632248)
Target
Alle BCKDK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- BCKDK antibody was raised against the N terminal of BCKDK
-
Aufreinigung
- Affinity purified
-
Immunogen
- BCKDK antibody was raised using the N terminal of BCKDK corresponding to a region with amino acids CLPFIIGCNPTILHVHELYIRAFQKLTDFPPIKDQADEAQYCQLVRQLLD
-
-
-
-
Applikationshinweise
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
BCKDK Blocking Peptide, (ABIN937128), is also available for use as a blocking control in assays to test for specificity of this BCKDK antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCKDK antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase (BCKDK))
-
Andere Bezeichnung
- BCKDK
-
Hintergrund
- BCkDaK belongs to the PDK/BCkDaK protein kinase family. It contains 1 histidine kinase domain. BCkDaK catalyzes the phosphorylation and inactivation of the branched-chain alpha-ketoacid dehydrogenase complex, the key regulatory enzyme of the valine, leucine and isoleucine catabolic pathways. BCkDaK is the key enzyme that regulates the activity state of the BCkDa complex.
-
Molekulargewicht
- 43 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-